{"id":"tp-40299","type":"article-newspaper","title":"Pfizer Candidate Shows Immune Response Across 25 Serotypes in Phase 2","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/40299","datePublished":"2026-10-24T20:11:56.000Z","dateModified":"2026-10-24T20:11:56.000Z","language":"en","abstract":"A four-dose series of PF-07872412 was evaluated, with safety and tolerability also reported.","section":"Business","references":[]}